Business Description
Tevogen Bio Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US88165K1016
Description
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | -1.44 | |||||
| Debt-to-Equity | -0.48 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.2 | |||||
| 9-Day RSI | 49.17 | |||||
| 14-Day RSI | 45.97 | |||||
| 6-1 Month Momentum % | 92.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.34 | |||||
| Quick Ratio | 0.34 | |||||
| Cash Ratio | 0.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 47.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 749.97 | |||||
| ROIC % | -559.7 | |||||
| ROC (Joel Greenblatt) % | 7279.94 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.83 | |||||
| PE Ratio without NRI | 17.12 | |||||
| EV-to-EBIT | 3.4 | |||||
| EV-to-EBITDA | 3.38 | |||||
| EV-to-FCF | -44.57 | |||||
| Earnings Yield (Greenblatt) % | 29.41 | |||||
| FCF Yield % | -2.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TVGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tevogen Bio Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.029 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 45.97 | ||
| 14-Day ATR ($) | 0.176312 | ||
| 20-Day SMA ($) | 1.08342 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.2556 - 21.09 | ||
| Shares Outstanding (Mil) | 175.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tevogen Bio Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tevogen Bio Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tevogen Bio Holdings Inc Frequently Asked Questions
What is Tevogen Bio Holdings Inc(TVGN)'s stock price today?
The current price of TVGN is $1.07. The 52 week high of TVGN is $21.09 and 52 week low is $0.26.
When is next earnings date of Tevogen Bio Holdings Inc(TVGN)?
The next earnings date of Tevogen Bio Holdings Inc(TVGN) is 2025-02-28 Est..
Does Tevogen Bio Holdings Inc(TVGN) pay dividends? If so, how much?
Tevogen Bio Holdings Inc(TVGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers